Teva Pharmaceutical CEO on Bringing His Company Back from the Brink | Barron's
Troubled Teva appoints new CEO in bid for direction | The Times of Israel
Teva expects to start paying U.S. opioid settlement in 2023 | Reuters
Teva names Lundbeck's Kåre Schultz as President and Chief Executive Officer - PharmaTimes
Teva denies outgoing CEO board role
Teva CEO Calls 'Trough' Revenues Consequence of Patent Expirations - YouTube
Cephalon's CEO vs Kåre Schultz | Comparably
Teva Pharmaceuticals on Twitter: "Speaking at #JPM2020, Teva CEO Kåre Schultz discussed the company's restructuring, future growth drivers, and a focus on the needs of patients and customers. Listen to a replay
Teva CEO steps down, replacement found
Teva's new CEO Schultz to take post Wednesday | The Times of Israel
Watch CNBC's full interview with Teva CEO Kåre Schultz
Teva Names Kare Schultz as President and Chief Executive Officer - Pharmaceutical Processing World
Serial Problem Solver
Kåre Schultz - Disability:IN
Teva Pharmaceuticals on Twitter: "Our live Q2 2022 earnings call is starting soon! Join President & CEO Kåre Schultz to discuss Teva's business performance and plans ahead. Join here: https://t.co/VR9FyBqEz2 #QuarterlyResults #Earnings $
Serial Problem Solver
Teva finally nabs a CEO, and it's Lundbeck helmsman—and Novo ex—Kåre Schultz | Fierce Pharma
Kåre Schultz - Wikipedia
Teva CEO Kåre Schultz discusses company's latest quarter and opioid settlement - YouTube
Teva Investors Are Back on the Rollercoaster | Ctech
Teva Appoints Lundbeck's Schultz as CEO | Ctech
Kåre Schultz - President & CEO at Teva Pharmaceutical Industries | The Org
